The Synovial Sarcoma (SS18/SYT) 18q11.2 Gene Rearrangement by FISH test is a specialized molecular diagnostic used to confirm synovial sarcoma, a rare soft tissue cancer. This test employs Fluorescence In Situ Hybridization (FISH) to detect characteristic chromosomal translocations involving the SS18 gene at 18q11.2. It is performed on tumor tissue samples to provide definitive diagnosis, especially when histology is inconclusive, ensuring accurate classification and guiding appropriate treatment planning for patients with suspected synovial sarcoma.
Patients with suspected soft tissue sarcoma, especially when pathology suggests synovial sarcoma, benefit from this test.
It provides definitive confirmation of synovial sarcoma when histology or immunohistochemistry results are inconclusive.
It specifically detects synovial sarcoma by identifying the SS18/SYT gene rearrangement.
Yes, it provides definitive evidence of synovial sarcoma when gene rearrangement is detected.
No, this test is diagnostic for cancer, not hereditary risk, so counseling is not required.
No, it confirms diagnosis but does not predict tumor aggressiveness or prognosis.
...
Didn't recieved OTP Yet? Resend OTP